drugset / Trial / NCT06310005
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 3006337 Are Tolerated
RandomizedParallel-groupSingle-blindTreatment
Summary
The main objectives of this trial are to investigate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of BI 3006337 in healthy male subjects following s.c. administration of single rising doses and multiple doses over 6 weeks.
Timeline
- Start
- 2024-04-19
- Primary completion
- 2024-10-31
- Completion
- 2024-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 3006337 | Unknown | — | Subcutaneous |
Indications
No indication recorded.